Welcome to our dedicated page for Akoya Biosciences news (Ticker: AKYA), a resource for investors and traders seeking the latest updates and insights on Akoya Biosciences stock.
Akoya Biosciences, Inc. reports news tied to its spatial biology business, including spatial proteomics platforms, multiplex immunofluorescence assays and cancer research collaborations. Company updates have covered the PhenoCycler-Fusion platform, PhenoCode Discovery IO60 panel, single-cell spatial proteomics data resources, immuno-oncology studies and biopharma service offerings for biomarker and translational research.
Akoya news also includes operating and financial results, material agreements, shareholder voting matters, governance updates and capital-structure disclosures. In July 2025, Akoya completed a merger and became a wholly owned subsidiary of Quanterix, making its AKYA public-company news record relevant as historical reference for the former Nasdaq-listed issuer.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.